Skip to content
October 14, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Evan Lee Salim October 14, 2026 8 minutes read
a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness-2

NEW YORK, NY — As the world enters the second week of October, a month traditionally dominated by pink ribbons and messages of early detection, a global movement is preparing to shift the narrative toward the often-overlooked reality of Stage 4 breast cancer. On October 13, 2026, observed as National Metastatic Breast Cancer (MBC) Awareness Day, more than 325 iconic landmarks across the globe will be bathed in teal, green, and pink.

The #LightUpMBC campaign, organized by METAvivor Research and Support, aims to illuminate the stark realities of metastatic disease—the only stage of breast cancer that is terminal. This year’s initiative marks the largest coordinated effort in the organization’s history, spanning all 50 U.S. states and 20 countries. From the heights of One World Trade Center in New York to the mist of Niagara Falls and the terminals of Mactan-Cebu Airport in the Philippines, the world will stand in solidarity with those living with a disease that currently has no cure.

Main Facts: Redefining Breast Cancer Awareness

Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the bloodstream or lymphatic system to form new tumors in distant organs. Most commonly, MBC affects the bones, liver, lungs, and brain. Despite advancements in medical imaging and screening, MBC remains a devastating diagnosis. Some patients are "de novo" metastatic, meaning they are diagnosed at Stage 4 from the very beginning, while others see a recurrence years or even decades after completing treatment for early-stage cancer.

The #LightUpMBC campaign is more than a visual spectacle; it is a call to action. The choice of colors is deeply symbolic:

  • Teal represents healing and spirituality.
  • Green represents the triumph of spring over winter and the renewal of life.
  • Pink represents the origin of the disease in the breast.

Together, these colors signify the unique journey of the MBC community. While the "pink" movement has successfully raised billions for awareness and early detection, METAvivor points out that only a small fraction of general breast cancer research funding is dedicated to the metastatic stage—the stage responsible for nearly all breast cancer deaths.

The 2026 campaign culminates in "#LightUpMBC Live," a free virtual broadcast airing at 8 p.m. ET / 5 p.m. PT on October 13. The program will feature a mix of patient testimonials, scientific updates from leading oncologists, and performances by Broadway stars and award-winning musicians.

Chronology: From a Single Bridge to a Global Phenomenon

The origins of #LightUpMBC are rooted in a story of friendship and a final wish. In 2017, Jessica Moore, a young woman diagnosed with MBC, expressed a simple desire to see a local landmark lit in the MBC awareness colors to help people understand her disease. She passed away at the age of 36, but her best friend, Laura Inahara, turned that wish into a legacy.

  • 2017: The first landmark, the Memorial Bridge connecting Portsmouth, New Hampshire, to Kittery, Maine, illuminates in teal, green, and pink.
  • 2018–2020: The movement gains momentum through social media, with patients and families petitioning local governments and building owners to join the cause. The #LightUpMBC hashtag begins to trend during Breast Cancer Awareness Month.
  • 2021: Amid the challenges of the pandemic, the campaign transitions into a digital powerhouse, launching the first "#LightUpMBC Live" stream to connect a homebound community.
  • 2023–2025: The campaign crosses the $2 million mark in total funds raised for MBC-specific research. International participation explodes, with landmarks in Europe and Asia joining the roster.
  • 2026: The campaign reaches a record-breaking 325+ landmarks in 195 cities. To date, the initiative has raised over $2.7 million, every cent of which is funneled into Stage 4 research grants.

Supporting Data: The Statistics of a Silent Epidemic

The need for dedicated MBC research is underscored by sobering statistics provided by the National Cancer Institute and the American Cancer Society. In 2026, an estimated 42,670 people in the United States are expected to die from breast cancer. This averages out to approximately 117 deaths every single day.

A common misconception is that "clearing" early-stage breast cancer means a patient is "safe." However, data shows that 20% to 30% of women diagnosed with early-stage breast cancer will eventually progress to metastatic disease. Furthermore, the median survival rate after an MBC diagnosis is approximately three years, though research-driven advancements are beginning to push that window further for certain subtypes.

The funding gap remains the primary hurdle for advocacy groups. Historically, less than 5% of all breast cancer research funding has been allocated to studying metastasis. METAvivor was founded to bridge this gap, operating as a 501(c)(3) nonprofit that exclusively funds Stage 4 research. By utilizing a rigorous peer-review process involving both scientific experts and patient advocates, the organization ensures that the most promising, life-extending projects receive the necessary capital.

Official Responses: Voices from the Frontlines

The leadership of METAvivor and the founders of #LightUpMBC emphasize that this campaign is about reclaiming the narrative of October.

"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," said Dr. Kelly Shanahan, METAvivor Board President and a former OB-GYN. "My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important because it focuses on the science of why cancer spreads and how we can stop it. #LightUpMBC is the biggest contributor to this research and serves as a vital way to bring our community together."

Laura Inahara, the founder of the campaign, reflected on the emotional weight of the event’s growth. "Jessica Moore hoped to illuminate just one local landmark. Today, her legacy helps families around the world shine a light for the people they love. It teaches patients with MBC how to advocate for themselves and has raised millions for the research that will hopefully one day save lives like hers."

Tami Eagle Bowling, the #LightUpMBC Campaign Director and a 11-year survivor of MBC, will host this year’s live stream alongside Broadway’s Kara Lindsay. "We want people to see the faces behind the statistics," Bowling stated. "The live stream is a celebration of life, but it’s also a sobering reminder of why we need to keep fighting. We aren’t just ‘aware’—we are taking action."

Implications: The Shift from Terminal to Chronic

The #LightUpMBC campaign represents a broader shift in the field of oncology: the attempt to transform metastatic breast cancer from a terminal death sentence into a manageable chronic condition.

1. Scientific Advancement and Treatment Resistance
The primary challenge in treating MBC is "treatment resistance." While many patients respond well to initial therapies, the cancer cells eventually mutate and find ways to bypass the medication. This requires patients to be in perpetual treatment, moving from one "line" of therapy to the next. The funds raised by #LightUpMBC are critical for developing "next-generation" inhibitors and immunotherapies that can outmaneuver the cancer’s evolution.

2. The End of "Pinkwashing"
For decades, critics have argued that the "pink" branding of October glosses over the harsh realities of the disease—hair loss, financial toxicity, and death—in favor of a more marketable "survivor" narrative. #LightUpMBC forces the public to confront the fact that for the metastatic community, there is no "finishing treatment." By illuminating landmarks in teal and green, the campaign demands a seat at the table for those who are often excluded from the celebratory atmosphere of Breast Cancer Awareness Month.

3. Global Advocacy and Patient Agency
The 2026 campaign highlights the power of patient-led advocacy. In an era where healthcare can feel impersonal, METAvivor’s model involves patients in the grant-selection process. This ensures that research is not just scientifically sound but also addresses the quality-of-life concerns that matter most to those living with the disease.

4. The Psychological Impact of Visibility
For the estimated 168,000 people living with MBC in the U.S. alone, the psychological toll of being "invisible" in the breast cancer community can be profound. Seeing a world-renowned structure like the Willis Tower or Philadelphia City Hall lit in their specific colors provides a sense of validation and community.

As the lights turn on across 195 cities on the evening of October 13, the message is clear: the fight against breast cancer is not over until it is over for those at Stage 4. Through the #LightUpMBC campaign, the global community is being asked to look past the pink and see the light of those who are still fighting for more time.


How to Participate:
The public is encouraged to visit www.lightupmbc.org to find a map of participating landmarks. Supporters can share photos on social media using the hashtags #LightUpMBC and #METAvivor. Donations made during the #LightUpMBC Live event will go directly toward funding metastatic breast cancer research grants.

About the Author

Evan Lee Salim

Author

View All Posts

Post navigation

Previous: Strengthening Global Health: WHO Director-General Highlights Jordan’s Humanitarian Leadership

Related Stories

navigating-the-nexus-glp-1-medications-and-breast-cancer-an-evolving-landscape
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – An Evolving Landscape

Asro October 13, 2026
from-terminal-to-chronic-how-precision-research-and-ai-are-redefining-metastatic-breast-cancer-in-canada
  • Patient Advocacy and Support

From Terminal to Chronic: How Precision Research and AI are Redefining Metastatic Breast Cancer in Canada

Pevita Pearce October 13, 2026
navigating-the-nuances-glp-1-medications-and-their-emerging-relationship-with-breast-cancer
  • Patient Advocacy and Support

Navigating the Nuances: GLP-1 Medications and Their Emerging Relationship with Breast Cancer

Asro October 13, 2026

Recent Posts

  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
  • Strengthening Global Health: WHO Director-General Highlights Jordan’s Humanitarian Leadership
  • Beyond the Component: Why Fluid Management is the Silent Architect of Bioprocessing Success
  • Abram Scientific Secures $8.3M DARPA Contract to Accelerate Breakthrough Coagulation Diagnostic
  • A Visionary at the Helm: AAPS Appoints Dr. Patrick J. Sinko as Chief Science Officer

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness-2
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Evan Lee Salim October 14, 2026
strengthening-global-health-who-director-general-highlights-jordans-humanitarian-leadership
  • Breast Cancer Prevention and Lifestyle

Strengthening Global Health: WHO Director-General Highlights Jordan’s Humanitarian Leadership

Pevita Pearce October 14, 2026
beyond-the-component-why-fluid-management-is-the-silent-architect-of-bioprocessing-success
  • Treatment Innovations

Beyond the Component: Why Fluid Management is the Silent Architect of Bioprocessing Success

Neng Nana October 14, 2026
abram-scientific-secures-8-3m-darpa-contract-to-accelerate-breakthrough-coagulation-diagnostic
  • Treatment Innovations

Abram Scientific Secures $8.3M DARPA Contract to Accelerate Breakthrough Coagulation Diagnostic

Dwi Wanna October 14, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.